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Background: Prior studies have suggested that proton pump inhibitors (PPI) may impair the efficacy of clopidogrel. In 1 large scale observational 
study of PCI pts, higher incidence of MACE was observed in patients who received PPI compared to those who did not receive PPI.
Methods: We studied 2646 consecutive pts who underwent successful PCI for stable or unstable CAD (excluding cardiogenic shock) between 
2001- 2007 and were released alive without post-procedural MI, TVR, or stroke. Pts were divided into PPI (N=771) or No PPI (N=1875) groups 
depending on whether they were prescribed PPI at discharge or not. We assessed the occurrence of death from any cause, MI, death/MI, TVR, ST 
(definite or probable by ARC criteria), and MACE (composite of death, MI, TVR, or ST) at 180 days after PCI. Using propensity-adjusted Cox regression, 
we evaluated the independent impact of PPI use on outcomes.
Results: Baseline features: mean age 65 yrs, 69% male, 28% diabetic. The PPI group was older, and had greater prevalence of female gender, HTN, 
DM, dyslipidemia, PAD, prior CABG, MI, and PCI. The median (range) duration of dual anti-platelet therapy was 13 (1-66) months. In the PPI vs. No 
PPI groups, all outcomes were similar (figure). In multivariate analysis, the use of PPI did not show an independent association with any of the study 
outcomes.
Conclusions: Despite their significantly worse baseline features, PPI pts had similar outcomes as No PPI pts. Our data do not support an adverse 
impact of PPI on clinical outcomes after PCI.
